Adrenomed

Drug to treat severe sepsis

placeHohen Neuendorf, Brandenburg, Germany calendar_todayFounded 2009 groups18 employees language adrenomed.com

Registered entities

Social engagement

Social engagement: 2.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Wellington Partners Venture Capital, HBM Healthcare Investments.

Investor typeCountShare
Venture capital444%
Private equity111%
Other / undisclosed444%

Recent activity

19 May 2026
Product launch
enibarcimab
29 Jan 2026
Recognition
regulatory
21 Aug 2025
Product launch
Coming soon